Supplementary data for: Mechanism-Based Reporting Patterns of Infection-Related Adverse Events With Systemic Psoriasis Therapies in FAERS

This dataset contains supplementary materials supporting the manuscript "Mechanism-Based Reporting Patterns of Infection-Related Adverse Events With Systemic Psoriasis Therapies in FAERS". The deposited files include supplementary methods and supplementary tables for a retrospective pharmacovigilance disproportionality analysis of psoriasis-indicated reports from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), 2014 Q1 through 2025 Q3. The supplementary tables include drug-group definitions, infection preferred-term taxonomy outputs, cohort quality-control summaries, mechanism- and drug-level sensitivity analyses, infection-subcategory analyses, age-stratified analyses, concomitant-therapy analyses, false-discovery-rate adjusted p-values, COVID-excluded analyses, primary-suspect-only analyses, regulatory serious-outcome sensitivity analyses, and reporter-source distributions. Raw FAERS Quarterly Data Extract files are publicly available from the U.S. Food and Drug Administration.